- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Intralesional Triamcinolone Injection in the Management of Cutaneous Hemangiomas in Children | ||
| Medical Journal of Babylon | ||
| Article 1, Volume 9, Issue 1, 2012, Pages 182-187 | ||
| Authors | ||
| Arkan Hadi Ahm; Ashraf Hashim Ahmed; Fadel Abbas Alhamami | ||
| Abstract | ||
| Background: Infantile hemangiomas are the most common vascular tumors in children. Various approaches have been advocated in the management of hemangioma. This study was designed to evaluate the efficacy and safety of intralesional triamcinolone injection in the treatment of hemangioma. Patients and methods: All patients studied regarding the age, number of lesions, presence of any complications, site and size of lesion and the percentage of regression after treatment with steroid. The patients were treated with local injection of diluted triamcinolone (40 mg) with 5 ml normal saline in a dose of 3 – 5 mg/kg. The injection was given every 4 – 6 weeks. The number of injections varied from two to six. Results: The response was excellent (more than 75% regression in size) in 10 patients (42%), good (50-75% regression in size) in 6 patients (25%), poor (25-50% regression in size) in 5 patients (21%) and no response (less than 25% regression in size or no response at all) was seen in 3 patients (12%). Conclusion: Intralesional injection of triamcinolone is a safe and effective treatment of hemangiomas. To get optimum response, it should be used in patients below one year of age. | ||
|
Statistics Article View: 34 PDF Download: 13 |
||